Dietary supplements could “provide a moderate preventative value” for cardiometabolic syndrome (CMS), according to a recent review published in Frontiers in Cardiovascular Medicine.
Coenzyme Q10 supplementation may offer significant fatigue-alleviating effects for patients with chronic fatigue syndrome and for healthy individuals, according to a recent meta-analysis of 13 randomised control trials.
Supplement manufacturer NOW found in a new set of tests of CoQ10 and quercetin supplements sold on Amazon that quality problems persist for products sold on the site and in some ways may have gotten worse.
Omega-3 brand Nordic Naturals is expanding its sports nutrition offering with two new products with NSF International’s Certified for Sport Program verification.
With a newly constructed plant in Sherbrooke, Québec, now open, three new products launching, and the IP wars behind it, krill oil pioneer Neptune Technologies & Bioressources is in a ‘strong position’ moving forward, the company’s senior vice president...
A new form of CoQ10 has hit the market with the launch of an antioxidant supplement by New Zealand-based manufacturer MitoQ Ltd. As is often the case with this particular ingredient, the company’s marketing message is based on claims of greater bioavailability.
Supplementing the diet of old mice with Coenzyme Q10 may reverse some age-related impairments in cognitive and psychomotor functions, says a new study.
Vitamin-like nutrient CoQ10 can reduce mortality rates by half in patients with moderate to severe heart failure, researchers have concluded in what they say is the first adequately powered trial to do so.
The U.S. International Trade Commission (ITC) has terminated its investigation into alleged patent infringement of certain coenzyme Q10 (CoQ10) products and production methods following a complaint by Japan’s Kaneka Corporation.
CoQ10 supply to the nutraceutical market could be set to tighten as Mitsubishi Gas Chemical Company announces it will withdraw from the manufacture and sale of the ingredient.
Supplementing a Mediterranean-style diet with co-enzyme Q10 may reduce markers of inflammation and improve a range of health measures, including heart and joint health.
Daily supplements of co-enzyme Q10 may boost antioxidant defenses and reduce markers of oxidative stress in people with atherosclerosis, or hardening of the arteries, according to a new study from Taiwan.
Supplements of co-enzyme Q10 may counter the rise in oxidative stress associated with strenuous exercise and reduce subsequent muscle damage, says a new study with ultra-runners participating in a 50 km run across Europe’s highest road in the Sierra Nevada.
Co-enzyme Q10 suppliers ZMC-USA and Zhejiang Medicine Company, Ltd. have filed an amended complaint against Kaneka Corporation for damages in excess of $100 million in an ongoing dispute over CoQ10 patents.
Kaneka Corporation has voluntarily dismissed a patent infringement against ZMC-USA and Zhejiang Medicine Co. in a US District Court in Texas, but a case at the International Trade Commission (ITC) continues.
The opportunity to drive sales of CoQ10 to the healthcare practitioner market is “huge” and largely untapped, according to the boss of one leading supplier of dietary supplements to this market.
The U.S. International Trade Commission has voted to investigate certain coenzyme Q10 (CoQ10) products and production methods following a complaint by Japan’s Kaneka Corporation.
Japan’s Kaneka Corporation has filed a complaint with the US International Trade Commission (ITC) over alleged patent infringements by seven other suppliers.
Ingredient supplier ZMC-USA has filed a complaint against fellow CoQ10 supplier Kaneka Corporation over the Japanese company’s recent US patent for a CoQ10 production process.
Israel’s Herbamed expansion into North American continues, as the company announces that DVA America will be its exclusive agent for its Ultrasome CoQ10 ingredient in the Eastern US and Canada.
The US has a new CoQ10 entry as Israel’s Herbamed Ltd. teams up with Salt Lake City’s New Products Plus (NPP) as agent for its Ultrasome CoQ10 ingredient in the Western US.
Delivering co-enzyme Q10 complexed with beta-cyclodextrin may increase the bioavailability of the nutrient, with the benefits experienced by all, according to a new study.
Coenzyme Q10 (CoQ10) may not benefit mental function, and at high doses equivalent to 1700 mg per day may even be damaging, say findings from a mouse study.
When shopping, consumers very quickly decide on a brand’s worth and unless they are making positive ticks in their minds to an array of factors, it is likely they will pass your functional food by, according to a leading consultant.
Supplements of co-enzyme Q10 (CoQ10) may improve the motility and density of sperm in infertile men, according to a new study using Kaneka’s ingredient.
Growth in the CoQ10 sector is likely to occur through expansions into new markets and new product categories, according to a Euromonitor market analyst.
One of the leading global suppliers of CoQ10 – Japan’s Asahi Kasei Pharma – has said it is exiting the market by the end of the year, citing “continuing unprofitability”.
Illinois-based SourceOne Global Partners has launched new heart health citrus ingredients it says deliver water soluble benefits along with boosting the bioavailability of other heart health ingredients such as omega-3s, CoEnzymeQ10 and Tocotrienols.
Coenzyme Q10 may have enhanced solubility in water, and stability to heat and light if complexed with beta-cyclodextrin, says a new study from Slovenia.
Coenzyme Q10 is “highly safe for use as a dietary supplement”, and has an acceptable daily intake (ADI) of 12 mg per kg per day, says a new review from Kaneka.
A reduced formulation of Coenzyme Q10 was better absorbed than a standard commercial formulation in a senior population sample, suggests a small company-sponsored study.
Product tester Consumerlab.com has found most coenzyme Q10 dietary supplements – best known to benefit heart health – do exactly what they say on the tin.
After less than two years, BASF has terminated its presence in the
global CoEnzymeQ10 market, citing a lack of demand for its premium,
nanotechnology-driven, highly soluble and bioavailable ingredients.
Supplements of coenzyme Q10 may boost physical performance and
reduce feelings of tiredness associated with exercise, Japanese
researchers have reported.
Beverage manufacturers in the US are keen to leverage the
energy-boosting properties of CoQ10, with data revealing that the
ingredient is being increasingly used in energy drinks.
One of the bastions of the CoQ10 market in Japan, Kaneka Nutrients,
is bringing its ingredient to the US food and beverage
industries through PL Thomas.
Germany-based BASF has reported that its solubilizate co-enzyme
Q10, Solu Q10, has excellent bioavailability, compared to a small
number of other delivery forms for the nutrient.
Ingredient manufacturer Blue California announced it is introducing
a 40 percent concentration of coenzyme Q10, in response to the
dietary supplement industry's demand for higher concentrations.
Complexing co-enzyme Q10 (CoQ10) with gamma-cyclodextrin boosted
bioavailability of CoQ10 by about 35 per cent compared to a
microcrystalline cellulose-CoQ10 complex, say researchers from
CycloChem, Wacker-Chemie, and Kumamoto University...
As the science behind the understanding of coenzyme Q10 (CoQ10)
expands, so does the list of health conditions that could
potentially benefit from supplements.
BASF is introducing two new grades of coenzyme Q10 in the US next
week, which it says makes it the first company to offer customers a
choice between formulations for use in multivitamin tablets and for
softgels.
Swiss company Emmi has developed a new beverage concept to overcome
stability issues with coenzyme Q10 and other micronutrients, which
will appear on shelves in key European markets from this summer.
